| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ITOS | iTeos Therapeutics, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | Jan 04, 2022 | Sale | $42.66 | 215,122 | 9,176,849 | 4,571,618 | Jan 06, 2022, 04:12 PM | |
| ITOS | iTeos Therapeutics, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | Jan 05, 2022 | Sale | $42.03 | 30,347 | 1,275,484 | 4,484,728 | Jan 06, 2022, 04:12 PM | |
| ITOS | iTeos Therapeutics, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | Dec 07, 2021 | Sale | $33.22 | 32,558 | 1,081,697 | 4,732,696 | Dec 07, 2021, 06:33 PM | |
| ITOS | iTeos Therapeutics, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | Dec 03, 2021 | Sale | $34.79 | 33,749 | 1,173,965 | 4,784,185 | Dec 07, 2021, 06:33 PM | |
| ITOS | iTeos Therapeutics, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | Dec 06, 2021 | Sale | $32.59 | 17,083 | 556,766 | 4,765,665 | Dec 07, 2021, 06:33 PM | |
| ITOS | iTeos Therapeutics, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | Nov 30, 2021 | Sale | $35.09 | 56,801 | 1,993,236 | 4,943,551 | Dec 02, 2021, 06:53 PM | |
| ITOS | iTeos Therapeutics, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | Dec 01, 2021 | Sale | $34.28 | 20,742 | 710,988 | 4,886,448 | Dec 02, 2021, 06:53 PM | |
| ITOS | iTeos Therapeutics, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | Dec 02, 2021 | Sale | $33.96 | 62,230 | 2,113,193 | 4,826,021 | Dec 02, 2021, 06:53 PM | |
| ITOS | iTeos Therapeutics, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | Nov 26, 2021 | Sale | $35.75 | 21,210 | 758,282 | 4,980,974 | Nov 30, 2021, 04:49 PM | |
| ITOS | iTeos Therapeutics, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | Nov 29, 2021 | Sale | $34.49 | 17,356 | 598,543 | 4,953,860 | Nov 30, 2021, 04:49 PM | |
| ITOS | iTeos Therapeutics, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | Nov 22, 2021 | Sale | $37.52 | 35,333 | 1,325,817 | 5,105,986 | Nov 24, 2021, 06:38 PM | |
| ITOS | iTeos Therapeutics, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | Nov 23, 2021 | Sale | $36.22 | 33,476 | 1,212,340 | 5,053,334 | Nov 24, 2021, 06:38 PM | |
| ITOS | iTeos Therapeutics, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | Nov 24, 2021 | Sale | $36.29 | 60,808 | 2,206,509 | 5,044,587 | Nov 24, 2021, 06:38 PM | |
| ITOS | iTeos Therapeutics, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | Oct 18, 2021 | Sale | $27.14 | 10,320 | 280,085 | 5,137,214 | Oct 18, 2021, 04:33 PM | |
| ITOS | iTeos Therapeutics, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | Oct 15, 2021 | Sale | $27.62 | 18,295 | 505,300 | 5,150,947 | Oct 18, 2021, 04:33 PM | |
| ITOS | iTeos Therapeutics, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | Oct 12, 2021 | Sale | $27.09 | 14,260 | 386,303 | 5,246,571 | Oct 14, 2021, 05:26 PM | |
| ITOS | iTeos Therapeutics, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | Oct 13, 2021 | Sale | $27.13 | 35,023 | 950,174 | 5,211,548 | Oct 14, 2021, 05:26 PM | |
| ITOS | iTeos Therapeutics, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | Oct 14, 2021 | Sale | $27.30 | 45,719 | 1,248,129 | 5,165,829 | Oct 14, 2021, 05:26 PM | |
| ITOS | iTeos Therapeutics, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | Oct 11, 2021 | Sale | $27.24 | 81,684 | 2,225,072 | 5,260,831 | Oct 12, 2021, 04:33 PM | |
| ITOS | iTeos Therapeutics, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | Oct 07, 2021 | Sale | $27.00 | 1,922 | 51,894 | 5,345,915 | Oct 12, 2021, 04:33 PM | |
| ITOS | iTeos Therapeutics, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | Oct 08, 2021 | Sale | $27.01 | 3,400 | 91,834 | 5,342,515 | Oct 12, 2021, 04:33 PM | |
| ITOS | iTeos Therapeutics, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | Oct 01, 2021 | Sale | $27.00 | 11,471 | 309,717 | 5,382,496 | Oct 05, 2021, 04:31 PM | |
| ITOS | iTeos Therapeutics, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | Oct 04, 2021 | Sale | $27.06 | 34,659 | 937,873 | 5,347,837 | Oct 05, 2021, 04:31 PM | |
| ITOS | iTeos Therapeutics, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | Sep 30, 2021 | Sale | $27.00 | 3,836 | 103,572 | 5,393,967 | Sep 30, 2021, 05:05 PM | |
| ITOS | iTeos Therapeutics, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | Sep 28, 2021 | Sale | $27.00 | 32,154 | 868,158 | 5,397,803 | Sep 30, 2021, 05:05 PM | |
| ITOS | iTeos Therapeutics, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | Sep 23, 2021 | Sale | $27.97 | 61,800 | 1,728,432 | 5,458,833 | Sep 27, 2021, 05:51 PM | |
| ITOS | iTeos Therapeutics, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | Sep 24, 2021 | Sale | $27.81 | 8,221 | 228,626 | 5,449,412 | Sep 27, 2021, 05:51 PM | |
| ITOS | iTeos Therapeutics, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | Sep 27, 2021 | Sale | $27.09 | 19,455 | 527,036 | 5,429,957 | Sep 27, 2021, 05:51 PM | |
| ITOS | iTeos Therapeutics, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | Sep 21, 2021 | Sale | $27.47 | 32,858 | 902,609 | 5,543,354 | Sep 23, 2021, 04:18 PM | |
| ITOS | iTeos Therapeutics, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | Sep 22, 2021 | Sale | $27.54 | 23,921 | 658,784 | 5,519,433 | Sep 23, 2021, 04:18 PM | |
| ITOS | iTeos Therapeutics, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | Sep 16, 2021 | Sale | $28.47 | 35,565 | 1,012,536 | 5,693,358 | Sep 20, 2021, 06:30 PM | |
| ITOS | iTeos Therapeutics, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | Sep 17, 2021 | Sale | $28.82 | 76,473 | 2,203,952 | 5,616,885 | Sep 20, 2021, 06:30 PM | |
| ITOS | iTeos Therapeutics, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | Sep 20, 2021 | Sale | $27.49 | 40,673 | 1,117,965 | 5,599,142 | Sep 20, 2021, 06:30 PM | |
| CGEM | Cullinan Oncology, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | Sep 16, 2021 | Sale | $29.06 | 3,124 | 90,783 | 7,648,268 | Sep 20, 2021, 05:31 PM | |
| ITOS | iTeos Therapeutics, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | Sep 15, 2021 | Sale | $27.80 | 40,336 | 1,121,535 | 5,730,582 | Sep 16, 2021, 04:46 PM | |
| ITOS | iTeos Therapeutics, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | Sep 14, 2021 | Sale | $27.58 | 36,081 | 995,198 | 5,775,322 | Sep 16, 2021, 04:46 PM | |
| CGEM | Cullinan Oncology, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | Sep 14, 2021 | Sale | $29.17 | 7,106 | 207,282 | 7,657,817 | Sep 16, 2021, 04:45 PM | |
| CGEM | Cullinan Oncology, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | Sep 15, 2021 | Sale | $29.16 | 6,425 | 187,353 | 7,651,392 | Sep 16, 2021, 04:45 PM | |
| ITOS | iTeos Therapeutics, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | Sep 09, 2021 | Sale | $28.97 | 38,028 | 1,101,671 | 5,863,768 | Sep 13, 2021, 07:02 PM | |
| ITOS | iTeos Therapeutics, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | Sep 10, 2021 | Sale | $28.30 | 22,643 | 640,691 | 5,852,455 | Sep 13, 2021, 07:02 PM | |
| ITOS | iTeos Therapeutics, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | Sep 13, 2021 | Sale | $27.64 | 35,785 | 989,097 | 5,805,340 | Sep 13, 2021, 07:02 PM | |
| CGEM | Cullinan Oncology, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | Sep 09, 2021 | Sale | $29.35 | 13,727 | 402,887 | 7,674,449 | Sep 13, 2021, 06:24 PM | |
| CGEM | Cullinan Oncology, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | Sep 10, 2021 | Sale | $29.04 | 5,931 | 172,236 | 7,668,518 | Sep 13, 2021, 06:24 PM | |
| CGEM | Cullinan Oncology, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | Sep 13, 2021 | Sale | $29.10 | 3,595 | 104,615 | 7,664,923 | Sep 13, 2021, 06:24 PM | |
| ITOS | iTeos Therapeutics, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | Sep 07, 2021 | Sale | $29.18 | 50,996 | 1,488,063 | 5,953,372 | Sep 08, 2021, 07:19 PM | |
| ITOS | iTeos Therapeutics, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | Sep 08, 2021 | Sale | $28.65 | 20,236 | 579,723 | 5,903,369 | Sep 08, 2021, 07:19 PM | |
| CGEM | Cullinan Oncology, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | Sep 03, 2021 | Sale | $29.60 | 12,731 | 376,838 | 7,724,085 | Sep 08, 2021, 06:20 PM | |
| CGEM | Cullinan Oncology, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | Sep 07, 2021 | Sale | $29.04 | 25,067 | 727,946 | 7,699,018 | Sep 08, 2021, 06:20 PM | |
| CGEM | Cullinan Oncology, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | Sep 08, 2021 | Sale | $29.11 | 10,842 | 315,611 | 7,688,176 | Sep 08, 2021, 06:20 PM | |
| CGEM | Cullinan Oncology, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | Aug 31, 2021 | Sale | $29.82 | 2,838 | 84,625 | 7,759,840 | Sep 02, 2021, 05:26 PM | |
| CGEM | Cullinan Oncology, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | Sep 01, 2021 | Sale | $29.47 | 5,714 | 168,392 | 7,752,573 | Sep 02, 2021, 05:26 PM | |
| CGEM | Cullinan Oncology, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | Sep 02, 2021 | Sale | $29.46 | 15,757 | 464,201 | 7,736,816 | Sep 02, 2021, 05:26 PM | |
| CGEM | Cullinan Oncology, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | Aug 27, 2021 | Sale | $29.09 | 13,357 | 388,555 | 7,792,126 | Aug 31, 2021, 04:47 PM | |
| CGEM | Cullinan Oncology, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | Aug 30, 2021 | Sale | $29.30 | 31,001 | 908,329 | 7,761,125 | Aug 31, 2021, 04:47 PM | |
| CGEM | Cullinan Oncology, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | Aug 23, 2021 | Sale | $29.11 | 53,359 | 1,553,281 | 7,858,018 | Aug 25, 2021, 07:42 PM | |
| CGEM | Cullinan Oncology, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | Aug 24, 2021 | Sale | $29.48 | 50,822 | 1,498,233 | 7,807,196 | Aug 25, 2021, 07:42 PM | |
| CGEM | Cullinan Oncology, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | Aug 25, 2021 | Sale | $29.09 | 1,713 | 49,831 | 7,805,483 | Aug 25, 2021, 07:42 PM | |
| CGEM | Cullinan Oncology, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | Aug 11, 2021 | Sale | $29.05 | 2,510 | 72,915 | 7,911,377 | Aug 12, 2021, 04:55 PM | |
| HARP | Harpoon Therapeutics, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | May 28, 2021 | Sale | $21.12 | 13,885 | 293,315 | 6,374,904 | Jun 02, 2021, 06:09 PM | |
| HARP | Harpoon Therapeutics, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | Jun 01, 2021 | Sale | $20.44 | 18,491 | 377,956 | 6,353,213 | Jun 02, 2021, 06:09 PM | |
| HARP | Harpoon Therapeutics, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | Jun 02, 2021 | Sale | $20.50 | 25,118 | 514,919 | 6,328,095 | Jun 02, 2021, 06:09 PM | |
| HARP | Harpoon Therapeutics, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | May 27, 2021 | Sale | $20.26 | 13,961 | 282,850 | 6,385,589 | May 27, 2021, 07:40 PM | |
| HARP | Harpoon Therapeutics, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | May 26, 2021 | Sale | $20.04 | 3,198 | 64,088 | 6,399,550 | May 27, 2021, 07:40 PM | |
| HARP | Harpoon Therapeutics, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | May 21, 2021 | Sale | $20.21 | 10,907 | 220,430 | 6,407,748 | May 24, 2021, 08:11 PM | |
| HARP | Harpoon Therapeutics, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | May 24, 2021 | Sale | $20.12 | 5,000 | 100,600 | 6,402,748 | May 24, 2021, 08:11 PM | |
| HARP | Harpoon Therapeutics, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | May 18, 2021 | Sale | $20.67 | 18,402 | 380,369 | 6,448,201 | May 20, 2021, 07:20 PM | |
| HARP | Harpoon Therapeutics, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | May 19, 2021 | Sale | $20.39 | 17,833 | 363,615 | 6,430,368 | May 20, 2021, 07:20 PM | |
| HARP | Harpoon Therapeutics, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | May 20, 2021 | Sale | $20.34 | 11,713 | 238,242 | 6,418,655 | May 20, 2021, 07:20 PM | |
| HARP | Harpoon Therapeutics, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | May 13, 2021 | Sale | $20.06 | 4,855 | 97,391 | 6,478,169 | May 17, 2021, 05:23 PM | |
| HARP | Harpoon Therapeutics, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | May 14, 2021 | Sale | $20.04 | 6,900 | 138,276 | 6,471,269 | May 17, 2021, 05:23 PM | |
| HARP | Harpoon Therapeutics, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | May 17, 2021 | Sale | $20.07 | 4,666 | 93,647 | 6,466,603 | May 17, 2021, 05:23 PM | |
| HOWL | Werewolf Therapeutics, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | May 04, 2021 | Buy | $16.00 | 245,000 | 3,920,000 | 6,672,183 | May 06, 2021, 04:19 PM | |
| HARP | Harpoon Therapeutics, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | May 05, 2021 | Sale | $22.52 | 10,172 | 229,107 | 6,551,345 | May 06, 2021, 04:05 PM | |
| HARP | Harpoon Therapeutics, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | Apr 21, 2021 | Sale | $18.97 | 8,972 | 170,229 | 7,020,675 | Apr 22, 2021, 04:04 PM | |
| HARP | Harpoon Therapeutics, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | Apr 16, 2021 | Sale | $19.86 | 5,847 | 116,110 | 7,061,697 | Apr 20, 2021, 06:07 PM | |
| HARP | Harpoon Therapeutics, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | Apr 19, 2021 | Sale | $19.30 | 10,056 | 194,059 | 7,051,441 | Apr 20, 2021, 06:07 PM | |
| HARP | Harpoon Therapeutics, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | Apr 20, 2021 | Sale | $18.71 | 22,249 | 416,382 | 7,029,926 | Apr 20, 2021, 06:07 PM | |
| HARP | Harpoon Therapeutics, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | Apr 15, 2021 | Sale | $20.49 | 8,696 | 178,181 | 7,067,244 | Apr 15, 2021, 08:00 PM | |
| HARP | Harpoon Therapeutics, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | Apr 13, 2021 | Sale | $19.46 | 16,054 | 312,369 | 7,092,108 | Apr 15, 2021, 08:00 PM | |
| HARP | Harpoon Therapeutics, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | Apr 14, 2021 | Sale | $20.77 | 13,806 | 286,809 | 7,088,746 | Apr 15, 2021, 08:00 PM | |
| ITOS | iTeos Therapeutics, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | Apr 09, 2021 | Sale | $29.99 | 200 | 5,998 | 6,004,368 | Apr 13, 2021, 04:15 PM | |
| CGEM | Cullinan Management, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | Jan 12, 2021 | Buy | $21.00 | 300,000 | 6,300,000 | 7,913,887 | Jan 14, 2021, 05:54 PM | |
| ONCR | Oncorus, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | Oct 06, 2020 | Buy | $15.00 | 151,224 | 2,268,360 | 2,377,025 | Oct 08, 2020, 06:26 PM | |
| ITOS | iTeos Therapeutics, Inc. | UBS Oncology Impact Fund L.P. | X* | Jul 28, 2020 | Buy | $19.00 | 320,000 | 6,080,000 | 2,355,557 | Jul 30, 2020, 08:00 AM | |
| TCRR | TCR2 THERAPEUTICS INC. | UBS Oncology Impact Fund L.P. | 10% Owner | Feb 19, 2019 | Buy | $15.00 | 666,667 | 10,000,005 | 3,370,982 | Feb 21, 2019, 06:06 PM | |
| HARP | Harpoon Therapeutics, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | Feb 12, 2019 | Sale | $9.30 | 377,543 | 3,512,511 | 3,898,422 | Feb 14, 2019, 05:34 PM | |
| SNSS | SUNESIS PHARMACEUTICALS INC | UBS Oncology Impact Fund L.P. | 10% Owner | Nov 02, 2017 | Buy | $2.59 | 25,300 | 65,527 | 3,275,300 | Nov 06, 2017, 09:27 PM | |
| SNSS | SUNESIS PHARMACEUTICALS INC | UBS Oncology Impact Fund L.P. | 10% Owner | Nov 03, 2017 | Buy | $2.89 | 40,000 | 115,600 | 3,315,300 | Nov 06, 2017, 09:27 PM | |
| SNSS | SUNESIS PHARMACEUTICALS INC | UBS Oncology Impact Fund L.P. | 10% Owner | Nov 06, 2017 | Buy | $2.77 | 16,200 | 44,874 | 3,331,500 | Nov 06, 2017, 09:27 PM |
Menu